{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T13:04:32Z","timestamp":1771506272102,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s12519-021-00470-9","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T12:02:32Z","timestamp":1636113752000},"page":"626-636","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Haploidentical hematopoietic stem cell transplantation for pediatric patients with chronic active Epstein\u2013Barr virus infection: a retrospective analysis of a single center"],"prefix":"10.1007","volume":"17","author":[{"given":"Yan-Hui","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7046-2417","authenticated-orcid":false,"given":"Ang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang-Hua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Guang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao-Quan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian-You","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,5]]},"reference":[{"key":"470_CR1","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","volume":"1","author":"MA Epstein","year":"1964","unstructured":"Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from burkitt\u2019s lymphoma. Lancet. 1964;1:702\u20133.","journal-title":"Lancet"},{"issue":"2","key":"470_CR2","first-page":"108","volume":"71","author":"K Kawa","year":"2000","unstructured":"Kawa K. Epstein-Barr virus\u2013associated diseases in humans. Int J Hematol. 2000;71:108\u201317.","journal-title":"Int J Hematol"},{"key":"470_CR3","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.3389\/fimmu.2017.01867","volume":"8","author":"H Kimura","year":"2017","unstructured":"Kimura H, Cohen JI. Chronic active epstein-barr virus disease. Front Immunol. 2017;8:1867.","journal-title":"Front Immunol"},{"key":"470_CR4","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1182\/blood-2018-03-785931","volume":"131","author":"CM Bollard","year":"2018","unstructured":"Bollard CM, Cohen JI. How I treat T-cell chronic active Epstein-Barr virus disease. Blood. 2018;131:2899\u2013905.","journal-title":"Blood"},{"key":"470_CR5","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s12185-017-2192-6","volume":"105","author":"A Sawada","year":"2017","unstructured":"Sawada A, Inoue M, Kawa K. How we treat chronic active Epstein-Barr virus infection. Int J Hematol. 2017;105:406\u201318.","journal-title":"Int J Hematol"},{"key":"470_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2174\/1573396311666150501002809","volume":"11","author":"M Okano","year":"2015","unstructured":"Okano M. Recent concise viewpoints of chronic active Epstein-Barr virus infection. Curr Pediatr Rev. 2015;11:5\u20139.","journal-title":"Curr Pediatr Rev"},{"key":"470_CR7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/ajh.20398","volume":"80","author":"M Okano","year":"2005","unstructured":"Okano M, Kawa K, Kimura H, Yachie A, Wakiguchi H, Maeda A, et al. Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. Am J Hematol. 2005;80:64\u20139.","journal-title":"Am J Hematol"},{"key":"470_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1440-1827.2008.02213.x","volume":"58","author":"K Ohshima","year":"2008","unstructured":"Ohshima K, Kimura H, Yoshino T, Kim CW, Ko YH, Lee SS, et al. Proposed categorization of pathological states of EBV-associated T\/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD. Pathol Int. 2008;58:209\u201317.","journal-title":"Pathol Int"},{"key":"470_CR9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124\u201331.","journal-title":"Pediatr Blood Cancer"},{"key":"470_CR10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","volume":"22","author":"AC Harris","year":"2016","unstructured":"Harris AC, Young R, Devine S, Hogan WJ, Ayuk F, Bunworasate U, et al. International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the mount sinai acute GVHD international consortium. Biol Blood Marrow Transplant. 2016;22:4\u201310.","journal-title":"Biol Blood Marrow Transplant"},{"key":"470_CR11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","volume":"21","author":"MH Jagasia","year":"2015","unstructured":"Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, et al. National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I The 2014 diagnosis and staging working group report. Biol Blood Marrow Transplant. 2015;21:389-401.e1.","journal-title":"Biol Blood Marrow Transplant."},{"key":"470_CR12","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1097\/TP.0b013e3181f24e8d","volume":"90","author":"BS Cho","year":"2010","unstructured":"Cho BS, Yahng SA, Lee SE, Eom KS, Kim YJ, Kim HJ, et al. Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation. Transplantation. 2010;90:918\u201326.","journal-title":"Transplantation"},{"key":"470_CR13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3389\/fimmu.2020.00489","volume":"11","author":"F Bonifazi","year":"2020","unstructured":"Bonifazi F, Barbato F, Ravaioli F, Sessa M, Defrancesco I, Arpinati M, et al. Diagnosis and treatment of VOD\/SOS After allogeneic hematopoietic stem cell transplantation. Front Immunol. 2020;11:489.","journal-title":"Front Immunol"},{"key":"470_CR14","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/bmt.2011.140","volume":"47","author":"AA Hamidieh","year":"2012","unstructured":"Hamidieh AA, Pourpak Z, Hosseinzadeh M, Fazlollahi MR, Alimoghaddam K, Movahedi M, et al. Reduced-intensity conditioning hematopoietic SCT for pediatric patients with LAD-1: clinical efficacy and importance of chimerism. Bone Marrow Transplant. 2012;47:646\u201350.","journal-title":"Bone Marrow Transplant"},{"key":"470_CR15","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1182\/blood-2002-01-0172","volume":"100","author":"JI Henter","year":"2002","unstructured":"Henter JI, Samuelsson-Horne A, Aric\u00f2 M, Egeler RM, Elinder G, Filipovich AH, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood. 2002;100:2367\u201373.","journal-title":"Blood"},{"issue":"1","key":"470_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s13023-021-01909-y","volume":"16","author":"H Ma","year":"2021","unstructured":"Ma H, Zhang L, Wei A, Jun Y, Dong W, Qing Z, et al. Outcome of L-DEP regimen for treatment of pediatric chronic active Epstein-Barr virus infection. Orphanet J Rare Dis. 2021;16:269.","journal-title":"Orphanet J Rare Dis"},{"key":"470_CR17","doi-asserted-by":"publisher","first-page":"e622","DOI":"10.1542\/peds.2006-3164","volume":"120","author":"N Mahlaoui","year":"2007","unstructured":"Mahlaoui N, Ouach\u00e9e-Chardin M, de Saint BG, Neven B, Picard C, Blanche S, et al. Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients. Pediatrics. 2007;120:e622\u20138.","journal-title":"Pediatrics"},{"key":"470_CR18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","volume":"15","author":"S Giralt","year":"2009","unstructured":"Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M, et al. Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant. 2009;15:367\u20139.","journal-title":"Biol Blood Marrow Transplant."},{"key":"470_CR19","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/ped4.12096","volume":"2","author":"C Jia","year":"2019","unstructured":"Jia C, Wang B, Zhu G, Zhang R, Wang K, Yan Y, et al. Haploidentical hematopoietic stem cell transplantation using reduced-intensity conditioning for pediatric patients with familial hemophagocytic lymphohistiocytosis. Pediatr Investig. 2019;2:216\u201321.","journal-title":"Pediatr Investig"},{"key":"470_CR20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/sj.bmt.1703796","volume":"31","author":"T Okamura","year":"2003","unstructured":"Okamura T, Kishimoto T, Inoue M, Honda M, Yamashita N, Wakiguchi H, et al. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T\/NK-cell lymphoproliferative disease. Bone Marrow Transplant. 2003;31:105\u201311.","journal-title":"Bone Marrow Transplant"},{"key":"470_CR21","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","volume":"119","author":"H Kimura","year":"2012","unstructured":"Kimura H, Ito Y, Kawabe S, Gotoh K, Takahashi Y, Kojima S, et al. EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood. 2012;119:673\u201386.","journal-title":"Blood"},{"key":"470_CR22","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/ajh.21247","volume":"83","author":"E Sato","year":"2008","unstructured":"Sato E, Ohga S, Kuroda H, Yoshiba F, Nishimura M, Nagasawa M, et al. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T\/natural killer-cell lymphoproliferative disease in Japan. Am J Hematol. 2008;83:721\u20137.","journal-title":"Am J Hematol"},{"key":"470_CR23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fped.2019.00014","volume":"7","author":"A Arai","year":"2019","unstructured":"Arai A. Advances in the study of chronic active Epstein-Barr Virus infection: clinical features under the 2016 WHO classification and mechanisms of development. Front Pediatr. 2019;7:14.","journal-title":"Front Pediatr"},{"key":"470_CR24","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.3390\/cancers12113202","volume":"12","author":"S Fujiwara","year":"2020","unstructured":"Fujiwara S, Nakamura H. Chronic active Epstein-Barr Virus infection: is it immunodeficiency, malignancy, or both? Cancers (Basel). 2020;12:3202.","journal-title":"Cancers (Basel)"},{"key":"470_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/bmt.2010.122","volume":"46","author":"K Kawa","year":"2011","unstructured":"Kawa K, Sawada A, Sato M, Okamura T, Sakata N, Kondo O, et al. Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection. Bone Marrow Transplant. 2011;46:77\u201383.","journal-title":"Bone Marrow Transplant"},{"key":"470_CR26","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1086\/587671","volume":"46","author":"K Gotoh","year":"2008","unstructured":"Gotoh K, Ito Y, Shibata-Watanabe Y, Kawada J, Takahashi Y, Yagasaki H, et al. Clinical and virological characteristics of 15 patients with chronic active Epstein-Barr virus infection treated with hematopoietic stem cell transplantation. Clin Infect Dis. 2008;46:1525\u201334.","journal-title":"Clin Infect Dis"},{"key":"470_CR27","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s10875-020-00795-6","volume":"40","author":"J Yang","year":"2020","unstructured":"Yang J, Zhu GH, Wang B, Zhang R, Jia CG, Yan Y, et al. Haploidentical hematopoietic stem cell transplantation for xiap deficiency: a single-center report. J Clin Immunol. 2020;40:893\u2013900.","journal-title":"J Clin Immunol"},{"key":"470_CR28","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s00277-017-3056-0","volume":"96","author":"E Leon Rodriguez","year":"2017","unstructured":"Leon Rodriguez E, Rivera Franco MM, Perez Alvarez SI. Reduced BUCY 2 and G-CSF-primed bone marrow associates with low graft-versus-host-disease and transplant-related mortality in allogeneic HSCT. Ann Hematol. 2017;96:1525\u201331.","journal-title":"Ann Hematol"},{"key":"470_CR29","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1182\/blood-2005-05-2146","volume":"107","author":"DP Lu","year":"2006","unstructured":"Lu DP, Dong L, Wu T, Huang XJ, Zhang MJ, Han W, et al. Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched\/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. Blood. 2006;107:3065\u201373.","journal-title":"Blood"},{"key":"470_CR30","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1053\/j.seminoncol.2012.09.003","volume":"39","author":"YJ Chang","year":"2012","unstructured":"Chang YJ, Huang XJ. Haploidentical bone marrow transplantation without T-cell depletion. Semin Oncol. 2012;39:653\u201363.","journal-title":"Semin Oncol"},{"key":"470_CR31","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1537-2995.2004.00700.x","volume":"44","author":"JN George","year":"2004","unstructured":"George JN, Li X, McMinn JR, Terrell DR, Vesely SK, Selby GB. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma. Transfusion. 2004;44:294\u2013304.","journal-title":"Transfusion"},{"key":"470_CR32","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1111\/bjh.16457","volume":"189","author":"N Epperla","year":"2020","unstructured":"Epperla N, Li A, Logan B, Fretham C, Chhabra S, Aljurf M, et al. Incidence, risk factors for and outcomes of transplant-associated thrombotic microangiopathy. Br J Haematol. 2020;189:1171\u201381.","journal-title":"Br J Haematol"},{"key":"470_CR33","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1182\/blood-2011-02-321315","volume":"118","author":"BL Laskin","year":"2011","unstructured":"Laskin BL, Goebel J, Davies SM, Jodele S. Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Blood. 2011;118:1452\u201362.","journal-title":"Blood"},{"key":"470_CR34","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12985-020-01409-8","volume":"17","author":"H Xiao","year":"2020","unstructured":"Xiao H, Hu B, Luo R, Hu H, Zhang J, Kuang W, et al. Chronic active Epstein-Barr virus infection manifesting as coronary artery aneurysm and uveitis. Virol J. 2020;17:166.","journal-title":"Virol J"},{"key":"470_CR35","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s00246-008-9343-8","volume":"30","author":"H Xiao","year":"2009","unstructured":"Xiao H, Hu B, Luo R, Hu H, Zhang J, Kuang W, et al. Cardiovascular complications associated with chronic active Epstein-Barr virus infection. Pediatr Cardiol. 2009;30:274\u201381.","journal-title":"Pediatr Cardiol"},{"key":"470_CR36","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/bjh.15267","volume":"181","author":"NA Kernan","year":"2018","unstructured":"Kernan NA, Grupp S, Smith AR, Arai S, Triplett B, Antin JH, et al. Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease\/sinusoidal obstruction syndrome. Br J Haematol. 2018;181:816\u201327.","journal-title":"Br J Haematol"}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-021-00470-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12519-021-00470-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-021-00470-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T12:49:25Z","timestamp":1659098965000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12519-021-00470-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,5]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["470"],"URL":"https:\/\/doi.org\/10.1007\/s12519-021-00470-9","relation":{},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,5]]},"assertion":[{"value":"31 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No financial or non-financial benefits have been received or will be received from any party related directly or indirectly to the subject of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board (IRB) of Beijing Children\u2019s Hospital, Capital Medical University ([2021]-A-123-R). Informed consent to participate in the study have been obtained from their parent or legal guardian in the case of children under 16.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}